[{"Assets_0_Q2_USD":78234360.0,"CommonStockSharesOutstanding_0_Q2_shares":102929257.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":6057415.0,"NetIncomeLoss_1_Q2_USD":10959948.0,"NetIncomeLoss_2_Q2_USD":10315445.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":102869202.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":102808897.0,"StockholdersEquity_0_Q2_USD":63281567.0,"EarningsPerShareBasic_1_Q2_USD":0.11,"EarningsPerShareBasic_2_Q2_USD":0.1,"Ticker":"CPRX","CIK":"1369568","name":"CATALYST PHARMACEUTICALS, INC.","OfficialName":"Catalyst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"872304311.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]